Pharmaceutical Translation Services UK
Translation support for pharmaceutical, clinical research and medicine-related content. From trial materials and scientific reports to product information and safety documents, send your source files and target languages to review the required terminology, audience and quality checks.
UK and international projects · Technical, regulatory and patient-facing materials
Pharmaceutical documents we can translate
Document type determines which clinical terminology, readability, review and formatting requirements should be considered.
Clinical trial documents
Protocols, participant information sheets, informed consent forms, diaries, questionnaires and study correspondence.
Regulatory documents
Dossier sections, agency correspondence and supporting product information for regulatory review, following client instructions.
Medicine labelling and packaging
Product names, strengths, dosage instructions, packaging and warnings for review in the destination market.
Patient information leaflets
Patient-facing leaflets and instructions where clear language and accurate safety information are essential.
Safety and pharmacovigilance
Adverse event narratives, follow-up reports and medical correspondence requiring careful handling of dates and dose information.
Scientific and technical materials
Research papers, SOPs, training documents, manufacturing information and other specialist texts.
For further details, see our pharmaceutical document translation services.
Why pharmaceutical translation accuracy matters
Errors in medicine names, active ingredients, strength, dosage units, administration routes, dates or safety warnings can change a document's meaning. Fluency alone does not establish suitability for patients, clinical researchers or regulatory use.
Scope the review to the material: patient leaflets need understandable wording; technical dossiers may need terminology control, tracked changes and approved reference text. Bilingual review, specialist assessment, reconciliation or back translation can be agreed where relevant rather than assumed to apply to all work.
Quality checks to consider
- Terminology: medicines, diseases, indications and approved names
- Numbers: doses, concentrations, dates, strengths and units
- Completeness: warnings, tables, notes and cross-references
- Consistency: repeated terms and language versions
- Readability: wording appropriate for the intended audience
- Approval: defined reviewer and final sign-off responsibilities
Pharmaceutical translation for UK MHRA and EU EMA requirements
Product-information requirements differ by market. The responsible sponsor or marketing authorisation holder should provide the applicable regulatory instructions and approved source text.
UK: MHRA guidance
The Medicines and Healthcare products Regulatory Agency explains UK medicines labelling and patient information leaflet requirements, including the need for clear and readable content. Read UK packaging and leaflet guidance and MHRA leaflet best practice, updated in July 2026.
EU: EMA product information
For relevant EU centralised procedures, the European Medicines Agency publishes QRD product-information templates and linguistic review procedures. Current templates, terminology and submission instructions must be checked for the relevant route.
Regulatory responsibility: Translation does not itself approve a leaflet, validate a trial or establish regulatory compliance. The responsible applicant, sponsor, manufacturer or regulatory reviewer makes those decisions.
Clinical trial and patient-facing translation
Consent forms, participant information, diaries and research questionnaires require careful attention to instructions, risks, choice and study terminology. For international trials, align the intended meaning across language versions while using clear language for each participant audience.
Research teams should confirm ethics approval, participant information and version sign-off separately. Translators should flag ambiguous source instructions rather than infer clinical detail that is not supplied.
What to share
- Current protocols, forms and source versions
- Participant audience and language variety
- Glossaries, product names and reference materials
- Any required bilingual review or reconciliation
- Formatting, confidentiality and approval requirements
Start your pharmaceutical translation project
A complete brief helps avoid unnecessary changes and makes specialist review responsibilities clear.
Send the files
Upload a readable source document, language pair and reference versions.
Specify the purpose
Share destination market, audience, terminology and deadline.
Agree the checks
Define the specialist review, revisions and sign-off where required.
Confirm delivery
Agree the formats, versions and client approval process.
Pharmaceutical translation costs
Costs depend on language pair, file volume, terminology, document complexity, format and agreed review stages. A multi-country regulatory package may require additional consistency checks and client approval cycles.
No fixed completion time applies to every clinical, regulatory or patient-facing document. Share the full files, destination and deadline before a turnaround is confirmed.
Factors affecting your project
- Languages, countries and target audience
- Clinical, regulatory or technical subject matter
- Tables, artwork, tracked changes and file formats
- Required terminology or medical review
- Version history and client-side sign-off
- Urgency and agreed output requirements
Pharmaceutical translation FAQs
What is pharmaceutical translation?
Translation of clinical, medicines-related, regulatory, patient-facing and technical content. Its requirements depend on the document and where it will be used.
Can clinical trial informed consent forms be translated?
Consent forms and participant information are common clinical research materials. Sponsors should define the appropriate language, ethics, approval and review requirements.
Do you translate medicine labels and leaflets?
Medicine labelling and patient information are within pharmaceutical language work. Source content, warnings, approved terminology and client-side regulatory review need to be considered.
What is the difference between MHRA and EMA guidance?
MHRA provides UK medicines guidance, while EMA maintains QRD product-information templates and linguistic review procedures for relevant EU authorisations. The route depends on the market.
Are translations automatically compliant with pharmaceutical regulations?
No. The relevant applicant, sponsor or marketing authorisation holder must arrange regulatory, medical and legal review and obtain necessary approvals.
Is back translation always required?
No. Back translation or reconciliation may be useful or specified by particular projects, but should be agreed in scope rather than assumed universal.
How do you protect medical terminology and numerical accuracy?
Share approved product names, terminology and source references. The project plan should specify checking names, units, quantities, dates, warnings and relevant cross-references.
How much do pharmaceutical translations cost?
Cost depends on language pairs, document length, subject complexity, format, revision needs, review stages and turnaround.
Can I start a pharmaceutical translation order online?
Yes. Start a written translation order with your document. For complex projects, use the enquiry form to clarify the scope and review stages.
What should I do before sharing confidential material?
Confirm the agreed transfer method, confidentiality arrangements, permitted recipients, personal data handling and document versions before sending sensitive files.
Explore pharmaceutical translation
Start your pharmaceutical translation order
Send source documents, languages, target countries, terminology and any required checks. For complex projects, include your stakeholder approval process and confidentiality requirements.
For specialist requirements, use the enquiry form below.